**Core Concept:** Sipuleucel-T is a biologic therapy that is used to boost the immune system's response against specific cancer cells. It is a type of cancer vaccine that stimulates the immune system to recognize and target cancer cells. The correct answer choice indicates the type of cancer for which Sipuleucel-T is used.

**Why the Correct Answer is Right:** Sipuleucel-T is a therapeutic cancer vaccine that targets prostate cancer cells by enhancing the immune system's response. It works by stimulating the immune system to recognize and attack prostate-specific antigen (PSA) expressing cancer cells. PSA is a protein produced by prostate cancer cells and serves as a marker for disease progression.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because Sipuleucel-T is not used for treating breast cancer. Breast cancer vaccines are not yet available, and Sipuleucel-T is specifically designed for prostate cancer.

B. This option is incorrect because Sipuleucel-T is not used for treating lung cancer. Although immunotherapies are being researched for lung cancer, Sipuleucel-T is specifically designed for prostate cancer.

C. This option is incorrect because Sipuleucel-T is not used for treating liver cancer. Hepatocellular carcinoma vaccines are being explored, but Sipuleucel-T is specifically designed for prostate cancer.

D. This option is correct because Sipuleucel-T is a therapeutic cancer vaccine used to treat prostate cancer. It enhances the immune system's response against prostate-specific antigen (PSA) expressing cancer cells.

**Clinical Pearl:** The development of immunotherapies for various types of cancer is an ongoing area of research. While Sipuleucel-T is approved for the treatment of advanced prostate cancer, new cancer vaccines and immunotherapies are being investigated for treating other types of cancer, such as lung, liver, breast, and ovarian cancers. However, these treatments are still in the research phase, and the correct answer (D) is the only one that accurately reflects the current clinical use of Sipuleucel-T.